Sign in

You're signed outSign in or to get full access.

Matthew McDonnell

Chief Financial Officer at Anteris Technologies Global
Executive

About Matthew McDonnell

Matthew McDonnell, age 53, is Chief Financial Officer (CFO) of Anteris Technologies Global Corp. (AVR) and serves as Principal Financial Officer and Principal Accounting Officer, having held the CFO role since November 2018 at Anteris’ predecessor (ATPL) and continuing post-Reorganization; he also serves as CFO of v2vmedtech since September 2023 . He spent over 24 years at KPMG, including 10 years as partner, delivering audit, accounting, and advisory services across multiple industries; he holds a Bachelor of Economics (Macquarie University) and is an Associate of Chartered Accountants ANZ, Fellow of FINSIA, and Member of the Australian Institute of Company Directors . The proxy does not disclose TSR or revenue/EBITDA growth attributable to his tenure.

Past Roles

OrganizationRoleYearsStrategic impact
KPMGPartner and senior roles24 years total; 10 years as partner Led audit/advisory across financial services, transport, industrials, health, childcare, energy; executed restructurings, acquisitions, divestments, privatizations

External Roles

OrganizationRoleYearsStrategic impact
v2vmedtech, inc.Chief Financial OfficerSince Sep 2023 Supports financing and development program for TEER device; v2v considered a VIE consolidated by AVR
State Library of QueenslandDirector and Chair of Audit & Risk Committee8 years Governance oversight of public institution’s audit/risk processes

Fixed Compensation

Employment agreement (McDonnell Contract) terms:

ComponentDetail
Base salary$236,246 (AUD $380,000), excluding superannuation; FX at ~A$1.00:$0.62 on Dec 31, 2024
Superannuation12.0% of eligible compensation (post Jul 1, 2024) subject to caps
Target annual bonus (STI)Up to 60% of base salary
Long-term incentive (LTI) at IPO$500,000 target grant-date fair value
Ongoing LTI from 2026$500,000 target grant value, service/performance-based; subject to stockholder approval per ASX rules
Termination noticeEither party may terminate with 3 months’ written notice
CovenantsNon-compete, non-solicit, IP, confidentiality

Actual reported compensation:

Metric20232024
Salary ($)$242,330 $267,432
Bonus ($)$50,000 (discretionary NASDAQ listing recognition)
Stock awards ($)$499,998
Option awards ($)$1,269,074
Non-equity incentive plan compensation ($)$105,262 $158,757
All other compensation ($)$20,146 $24,471
Total ($)$1,636,812 $1,000,658

Compensation structure observations:

  • Mix shifted from options-heavy (2023 option awards $1.27M) to RSUs/LTI and cash STI in 2024 ($500k RSU, $159k STI), with a $50k discretionary IPO-related bonus .

Performance Compensation

Short-term incentive (STI) plan and outcomes:

MetricWeightingTargetActualPayoutVesting
Adjusted EBITDANot disclosed Not disclosed Committee determined targets “sufficiently met” 100% of target STI bonus paid Cash, paid typically in March following year
Capital positionNot disclosed Not disclosed Sufficiently met 100% of target STI bonus paid Cash
Strategic objectives (THV program advancement; NASDAQ listing/IPO)Not disclosed Achieve listing and program milestones Achieved; additional discretionary bonuses awarded100% of target STI; plus $50,000 discretionary cash bonus to McDonnell Cash

Executive equity awards (vesting detail):

AwardQuantityVesting scheduleNotes
RSUs (IPO-related)83,333Vest in substantially equal installments on Dec 16, 2025; Dec 16, 2026; Dec 16, 2027, subject to continued employment RSU vesting accelerates upon termination following a change in control
SPP Units (Share Price Performance Plan)233,334Vest in substantially equal installments on Sep 13, 2025 and Sep 13, 2026, subject to continued employment SPP Units payout based on share price increases from base price; cash settlement post-vesting

Policies:

  • Compensation recovery (clawback) policy compliant with NASDAQ Listing Rules .
  • Grant timing not designed around MNPI; no 2024 option awards granted during blackout windows .

Equity Ownership & Alignment

Beneficial ownership and alignment indicators:

ItemDetail
Total beneficial ownership112,001 options exercisable within 60 days (held via Quadroo Pty Ltd as trustee for McDonnell Family Trust)
Ownership % of outstandingLess than 1%
Exercisable vs unexercisable options2,001 @ $4.23 (exp 7/12/2029) exercisable; 60,000 @ $5.52 (exp 9/23/2026) exercisable; 33,334 exercisable and 16,666 unexercisable @ $8.06 (exp 6/13/2027); the 16,666 unexercisable vest on Sep 19, 2025
RSUs outstanding83,333 RSUs vest 2025–2027
SPP Units outstanding233,334 SPP Units vest 2025–2026
Pledging/hedgingCompany policy prohibits short sales, public-traded options, hedging, margin accounts, and pledging for officers/directors/employees
Ownership guidelinesNot disclosed for executives in proxy; director policy detailed separately

Options detail:

NumberExercise price ($)ExpirationVesting
2,0014.237/12/2029Exercisable
60,0005.529/23/2026Exercisable
33,3348.066/13/2027Exercisable
16,6668.066/13/2027Unexercisable; vests 9/19/2025

Employment Terms

ProvisionDetail
RoleChief Financial Officer; Principal Financial Officer and Principal Accounting Officer (as evidenced by 10-Q certification)
Base salary$236,246 (AUD $380,000)
STI targetUp to 60% of base salary
LTI$500,000 at IPO; $500,000 annual LTI from 2026 subject to stockholder approval
Change-of-controlRSU vesting accelerates upon termination following a change in control
SeveranceNot specified beyond general 3 months notice; no cash severance multiple disclosed
CovenantsNon-compete, non-solicit, IP assignment, confidentiality

Investment Implications

  • Pay-for-performance linkage: McDonnell’s STI metrics (Adjusted EBITDA, capital position, strategic objectives including THV program and NASDAQ listing) tie his annual cash bonus to operational execution and financing posture; 100% STI payout and discretionary IPO bonus reflect successful 2024 objectives . RSUs and SPP Units create multi-year alignment with share price and service retention through 2027 .
  • Retention and selling pressure: Upcoming vesting events (RSUs in Dec 2025/2026/2027; SPP Units in Sep 2025/2026; options tranche vesting Sep 19, 2025) could coincide with Form 4 activity; company policy bans hedging/pledging, limiting forced selling via collateral, but vesting may add supply in windows .
  • Ownership alignment: Beneficial ownership is small (<1%), but sizeable unvested RSUs/SPP Units and exercisable options provide upside leverage to value creation; no executive ownership guideline disclosed in proxy .
  • Contract economics and risk: Limited severance (3 months’ notice) means retention relies on ongoing LTI grants and role scope; change-of-control accelerations for RSUs increase transaction incentives . Broader proposals to amend/reprice legacy options require stockholder approvals (ASX Listing Rules 6.23.4), a governance watchpoint though not specific to McDonnell’s current awards .
Citations: 
About/roles: **[2011514_0001140361-25-041377_ny20056476x2_def14a.htm:38]** **[2011514_0001140361-25-041377_ny20056476x2_def14a.htm:39]** **[2011514_0001140361-25-041643_ef20054952_ex31-2.htm:0]**; Fixed comp terms: **[2011514_0001140361-25-041377_ny20056476x2_def14a.htm:42]**; Summary compensation: **[2011514_0001140361-25-041377_ny20056476x2_def14a.htm:40]**; STI metrics/outcomes: **[2011514_0001140361-25-041377_ny20056476x2_def14a.htm:43]**; RSU/Spp/vesting: **[2011514_0001140361-25-041377_ny20056476x2_def14a.htm:44]** **[2011514_0001140361-25-041377_ny20056476x2_def14a.htm:47]**; Options detail: **[2011514_0001140361-25-041377_ny20056476x2_def14a.htm:47]**; Ownership table: **[2011514_0001140361-25-041377_ny20056476x2_def14a.htm:55]**; Insider policy (pledging/hedging): **[2011514_0001140361-25-041377_ny20056476x2_def14a.htm:33]**; Director compensation policy (ownership context): **[2011514_0001140361-25-041377_ny20056476x2_def14a.htm:36]**; Repricing proposals context: **[2011514_0001140361-25-041377_ny20056476x2_def14a.htm:1]** **[2011514_0001140361-25-041377_ny20056476x2_def14a.htm:12]** **[2011514_0001140361-25-041377_ny20056476x2_def14a.htm:16]**.